SS Innovations International (NASDAQ: SSII) is building momentum for its SSi Mantra surgical robotic system, with growing utilization in India providing a foundation for broader international expansion. More than 50 robotic procedures were performed with the system in a single day at Mohak Bariatrics and Robotics in Indore, while the company reported 224 SSi Mantra systems installed across 12 countries and a 143% year-over-year increase in robotic procedures during the second quarter of 2026. Quarterly revenue rose 39% to $13.9 million, with system sales increasing 41% to $12.4 million, while installations reached 30 systems during the quarter.
India remains the company’s primary commercial market, but SS Innovations is also pursuing regulatory expansion into Europe and the United States, with CE marking targeted for the end of 2026 and FDA review of its 510(k) application now expected by the end of the first quarter of 2027. The company is also developing telesurgery capabilities and expanding surgeon training as it seeks to grow utilization and establish its platform in additional markets. To view the full article, visit https://ibn.fm/6FPBS.
The growing adoption of the SSi Mantra system is significant because it demonstrates that robotic surgery can be made more affordable and accessible, potentially disrupting a market long dominated by expensive systems. The high-volume procedures at Mohak Bariatrics and Robotics highlight the system’s reliability and efficiency, which could accelerate adoption in other emerging markets. Moreover, the planned regulatory expansions into Europe and the U.S. represent a strategic move to compete in the largest healthcare markets, where demand for minimally invasive surgical options continues to rise.
SS Innovations International develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.
For investors, the strong financial performance and increasing procedure volumes suggest a scalable business model with significant growth potential. The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII. As the company continues to innovate and expand, it is poised to capture a larger share of the global surgical robotics market, which could drive long-term value.
For more information about TechMediaWire, visit TechMediaWire. TechMediaWire is part of the Dynamic Brand Portfolio @ IBN, which provides access to a vast network of wire solutions via InvestorWire and editorial syndication to 5,000+ outlets. Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer.
